96 related articles for article (PubMed ID: 4422035)
1. Pharmacology of 1, 2, 3, 4-tetrahydro-9-amino-acridine.
Fusek J; Patocka J; Bajgar J; Bielavský J; Herink J; Hrdina V
Act Nerv Super (Praha); 1974 Aug; 16(3):226. PubMed ID: 4422035
[No Abstract] [Full Text] [Related]
2. [Pharmacology of some carbamoyl derivatives of serotonin].
Mashkovskiĭ MD; Arutiunian GS
Farmakol Toksikol; 1971; 34(1):26-9. PubMed ID: 5563372
[No Abstract] [Full Text] [Related]
3. [Intestinal motor function in lengthy experiments under the action of MAO and AChE inhibitors].
Nagórna-Stasiak B
Acta Physiol Pol; 1970; 21(2):195-206. PubMed ID: 5507265
[No Abstract] [Full Text] [Related]
4. [Reactivity of isolated rat intestine to choline potentiating compounds].
Prozorovskiĭ VB; Khromova ON; Gladysheva NI
Farmakol Toksikol; 1971; 34(1):54-7. PubMed ID: 5563376
[No Abstract] [Full Text] [Related]
5. [Effect of monoamine oxidase inhibitors and acetylcholinesterase on the intestinal motor function].
Pytasz M; Nagórna-Stasiak B
Acta Physiol Pol; 1969; 20(2):319-27. PubMed ID: 5788451
[No Abstract] [Full Text] [Related]
6. In vivo kinetics of blood cholinesterase inhibition by 9-amino-1, 2, 3, 4-tetrahydroacridine, its 7-methoxy derivative and physostigmine in rats.
Bajgar J; Fusek J; Patocka J; Hrdina V
Physiol Bohemoslov; 1979; 28(1):31-4. PubMed ID: 155828
[TBL] [Abstract][Full Text] [Related]
7. Effect of physostigmine on cholinesterase activity in different parts of rat brain.
Osman MY; Abdel Tawab SM; Sharaf IA
Arzneimittelforschung; 1995 Jun; 45(6):663-5. PubMed ID: 7646566
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens.
Caricati-Neto A; D'angelo LC; Reuter H; Hyppolito Jurkiewicz N; Garcia AG; Jurkiewicz A
Eur J Pharmacol; 2004 Oct; 503(1-3):191-201. PubMed ID: 15496314
[TBL] [Abstract][Full Text] [Related]
9. Studies on acetylcholinesterase of rat brain synaptosomal plasma membranes.
Goodkin P; Howard BD
J Neurochem; 1974 Jan; 22(1):129-36. PubMed ID: 4818865
[No Abstract] [Full Text] [Related]
10. The mechanism of action of physostigmine at muscarinic receptors of rat myocardium.
Orsetti M
Boll Soc Ital Biol Sper; 1986 Jan; 62(1):67-73. PubMed ID: 3718728
[No Abstract] [Full Text] [Related]
11. [Pharmacology of circulatory active substances in stored milk].
Dhorranintra B; Hedler L; Marquardt P
Arzneimittelforschung; 1970 Jun; 20(6):802-8. PubMed ID: 4195644
[No Abstract] [Full Text] [Related]
12. Some pharmacological properties of RX 67668--a new anticholinesterase.
Doxey JC; Metcalf G; Smith MH; Whittle BA
Br J Pharmacol; 1972 Nov; 46(3):568P-569P. PubMed ID: 4656643
[No Abstract] [Full Text] [Related]
13. [Pyrilium, thiopyrilium and selenopyrilium salts--reversible cholinesterase inhibitors].
Brestkin AP; Dmitrieva EN; Zhukovskiĭ IuG; Safonova AA; Sedavkina VA
Dokl Akad Nauk SSSR; 1987; 293(6):1499-502. PubMed ID: 3608765
[No Abstract] [Full Text] [Related]
14. Relative binding sites of pharmacologically active ligands on bovine erythrocyte acetylcholinesterase.
Roufogalis BD; Quist EE
Mol Pharmacol; 1972 Jan; 8(1):41-9. PubMed ID: 5062233
[No Abstract] [Full Text] [Related]
15. [Study of the cholinesterase-inhibitors, eserine and mioticol].
Grijalbo Lizondo MP
Arch Inst Farmacol Exp (Madr); 1966; 18(1):27-48. PubMed ID: 5960114
[No Abstract] [Full Text] [Related]
16. Allosteric modulation of the nicotinic acetylcholine receptor by physostigmine.
Svobodová L; Krusek J; Hendrych T; Vyskocil F
Ann N Y Acad Sci; 2005 Jun; 1048():355-8. PubMed ID: 16154951
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.
Camps P; El Achab R; Görbig DM; Morral J; Muñoz-Torrero D; Badia A; Eladi Baños J; Vivas NM; Barril X; Orozco M; Luque FJ
J Med Chem; 1999 Aug; 42(17):3227-42. PubMed ID: 10464010
[TBL] [Abstract][Full Text] [Related]
18. [Allosteric properties of cholinesterases].
Dolgo-Saburov VB; Mukhamedzhanov EK
Ukr Biokhim Zh; 1972; 44(3):400-5. PubMed ID: 4575748
[No Abstract] [Full Text] [Related]
19. [Pharmacology of isopropylidene-proscillaridin].
Lenke D; Brock N
Arzneimittelforschung; 1970 Jan; 20(1):1-7. PubMed ID: 5467444
[No Abstract] [Full Text] [Related]
20. [Effect of chlorcholin chloride and N,N-dimethyl-(2-bromethyl)-hydrazinium bromide on the activity of cholinesterases in the erythrocytes and plasma of rat and man].
Henninghausen G; Tiefenbach B; Karnstedt U; Kröning G
Acta Biol Med Ger; 1973; 31(6):873-8. PubMed ID: 4791181
[No Abstract] [Full Text] [Related]
[Next] [New Search]
